Radiopharmaceuticals for sentinel lymph node detection

Auteur: International Atomic Energy Agency
Editeur: IAEA
Summarizes the current status and future trends in the development of radiopharmaceuticals for sentinel lymph node detection (SLND), an essential diagnostic tool for the effective treatment of superficial cancers such as breast tumours and melanoma.
Sur commande
Summarizes the current status and future trends in the development of radiopharmaceuticals for sentinel lymph node detection (SLND), an essential diagnostic tool for the effective treatment of superficial cancers such as breast tumours and melanoma.
ISBN / EAN 9789201097149
Auteur International Atomic Energy Agency
Editeur IAEA